{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:14:29Z","timestamp":1792588469234,"version":"4.5.0"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100014653","name":"NIHR Manchester BRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["20385"],"award-info":[{"award-number":["20385"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Immune-mediated inflammatory diseases (IMIDs) are characterized by dysregulation of the normal immune response, which leads to inflammation. Together, they account for a high disease burden in the population, given that they are usually chronic conditions with associated co-morbidities. Examples include systemic lupus erythematosus, rheumatoid arthritis, Crohn's disease and type 1 diabetes. Since the advent of genome-wide association studies, evidence of considerable genetic overlap in the loci predisposing to a wide range of IMIDs has emerged. Understanding the genetic risk and extent of genetic overlap between IMIDs may help to determine which genes control which aspects of the different diseases; it may identify potential novel therapeutic targets for a number of these conditions, and\/or it may facilitate repurposing existing therapies developed originally for different conditions. The findings show that autoantibody-mediated autoimmune diseases cluster more closely with each other than autoantibody-negative diseases such as psoriasis, psoriatic arthritis, Crohn's disease and ankylosing spondylitis which, instead, form a seronegative genetic cluster. The genetic clustering largely mirrors the known response to existing biological therapies, but apparent anomalies in treatment response are discussed.<\/jats:p>","DOI":"10.1111\/cei.13101","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T09:36:59Z","timestamp":1515749819000},"page":"3-12","source":"Crossref","is-referenced-by-count":96,"title":["Genetics of immune-mediated inflammatory diseases"],"prefix":"10.1093","volume":"193","author":[{"given":"T","family":"David","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Salford Royal NHS Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8148-2344","authenticated-orcid":false,"given":"S F","family":"Ling","sequence":"additional","affiliation":[{"name":"Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3316-2527","authenticated-orcid":false,"given":"A","family":"Barton","sequence":"additional","affiliation":[{"name":"Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester, UK"},{"name":"NIHR Manchester BRC, Central Manchester Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"2021120808395434000_cei13101-bib-0001","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev"},{"key":"2021120808395434000_cei13101-bib-0002","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0003","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/jamainternmed.2015.3528","article-title":"Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families","volume":"175","author":"Kuo","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2021120808395434000_cei13101-bib-0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1741-7015-11-73","article-title":"How do autoimmune diseases cluster in families? A systematic review and meta-analysis","volume":"11","author":"Cardenas-Roldan","year":"2013","journal-title":"BMC Med"},{"key":"2021120808395434000_cei13101-bib-0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fimmu.2016.00139","article-title":"The autoimmune ecology","volume":"7","author":"Anaya","year":"2016","journal-title":"Front Immunol"},{"key":"2021120808395434000_cei13101-bib-0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021120808395434000_cei13101-bib-0007","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/0961203313501400","article-title":"Cigarette smoking, alcohol consumption and risk of systemic lupus erythematosus","volume":"23","author":"Takvorian","year":"2014","journal-title":"Lupus"},{"key":"2021120808395434000_cei13101-bib-0008","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/ard.2004.022053","article-title":"Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study","volume":"64","author":"Stolt","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2021120808395434000_cei13101-bib-0009","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/BOR.0000000000000318","article-title":"Environmental exposures and the development of systemic lupus erythematosus","volume":"28","author":"Barbhaiya","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2021120808395434000_cei13101-bib-0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","article-title":"Occupational and environmental scleroderma. Systematic review and meta-analysis","volume":"36","author":"Rubio-Rivas","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2021120808395434000_cei13101-bib-0011","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/rheumatology\/32.10.903","article-title":"Twin concordance rates for rheumatoid arthritis: results from a nationwide study","volume":"32","author":"Silman","year":"1993","journal-title":"Br J Rheumatol"},{"key":"2021120808395434000_cei13101-bib-0012","article-title":"The inherited antigen (HL-A 27) and arthritis","volume":"55","author":"Brewerton","year":"1974","journal-title":"Rep Rheum Dis"},{"key":"2021120808395434000_cei13101-bib-0013","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(74)90930-1","article-title":"Letter: HL-A antigens and diabetes mellitus","volume":"2","author":"Cudworth","year":"1974","journal-title":"Lancet"},{"key":"2021120808395434000_cei13101-bib-0014","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM197804202981602","article-title":"Association of the B-cell alloantigen DRw4 with rheumatoid arthritis","volume":"298","author":"Stastny","year":"1978","journal-title":"N Engl J Med"},{"key":"2021120808395434000_cei13101-bib-0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar3204","article-title":"Promise and pitfalls of the immunochip","volume":"13","author":"Cortes","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2021120808395434000_cei13101-bib-0016","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"key":"2021120808395434000_cei13101-bib-0017","doi-asserted-by":"crossref","first-page":"eaal3062","DOI":"10.1126\/sciimmunol.aal3062","article-title":"Citrullination of NF-kappaB p65 promotes its nuclear localization and TLR-induced expression of IL-1beta and TNFalpha","volume":"2","author":"Sun","year":"2017","journal-title":"Sci Immunol"},{"key":"2021120808395434000_cei13101-bib-0018","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrrheum.2017.80","article-title":"The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping","volume":"13","author":"Eyre","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2021120808395434000_cei13101-bib-0019","doi-asserted-by":"crossref","first-page":"e1002254","DOI":"10.1371\/journal.pgen.1002254","article-title":"Pervasive sharing of genetic effects in autoimmune disease","volume":"7","author":"Cotsapas","year":"2011","journal-title":"PLoS Genet"},{"key":"2021120808395434000_cei13101-bib-0020","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ng.3330","article-title":"Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls","volume":"47","author":"Fortune","year":"2015","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0021","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.3528","article-title":"Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0022","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1038\/ncomms7046","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat Commun"},{"key":"2021120808395434000_cei13101-bib-0023","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host\u2013microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"key":"2021120808395434000_cei13101-bib-0024","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1002\/eji.200636217","article-title":"Role of MHC class II expressing CD4+ T cells in proteolipid protein(91\u2013110)-induced EAE in HLA-DR3 transgenic mice","volume":"36","author":"Mangalam","year":"2006","journal-title":"Eur J Immunol"},{"key":"2021120808395434000_cei13101-bib-0025","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"2021120808395434000_cei13101-bib-0026","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ng.2504","article-title":"Chromatin marks identify critical cell types for fine mapping complex trait variants","volume":"45","author":"Trynka","year":"2013","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.aut.2017.10.005","article-title":"An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis","author":"Nicol","year":"2017","journal-title":"J Autoimmun"},{"key":"2021120808395434000_cei13101-bib-0028","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ng.1076","article-title":"Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis","volume":"44","author":"Raychaudhuri","year":"2012","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0029","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/annrheumdis-2017-211414","article-title":"Cross phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis","volume":"76","author":"Bowes","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021120808395434000_cei13101-bib-0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","article-title":"A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis","volume":"75","author":"Begovich","year":"2004","journal-title":"Am J Hum Genet"},{"key":"2021120808395434000_cei13101-bib-0031","doi-asserted-by":"crossref","first-page":"26506","DOI":"10.1074\/jbc.M110.111104","article-title":"Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue","volume":"285","author":"Fiorillo","year":"2010","journal-title":"J Biol Chem"},{"key":"2021120808395434000_cei13101-bib-0032","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4049\/jimmunol.1502656","article-title":"Loss of the protein tyrosine phosphatase PTPN22 reduces mannan-induced autoimmune arthritis in SKG mice","volume":"197","author":"Sood","year":"2016","journal-title":"J Immunol"},{"key":"2021120808395434000_cei13101-bib-0033","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cei.12393","article-title":"The protein tyrosine phosphatase PTPN22 controls forkhead box protein 3 T regulatory cell induction but is dispensable for T helper type 1 cell polarization","volume":"178","author":"Fousteri","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2021120808395434000_cei13101-bib-0034","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4049\/jimmunol.1700601","article-title":"The autoimmune risk variant PTPN22 C1858T alters B cell tolerance at discrete checkpoints and differentially shapes the naive repertoire","volume":"199","author":"Metzler","year":"2017","journal-title":"J Immunol"},{"key":"2021120808395434000_cei13101-bib-0035","doi-asserted-by":"crossref","first-page":"aaf7153","DOI":"10.1126\/sciimmunol.aaf7153","article-title":"PTPN22 inhibition resets defective human central B cell tolerance","volume":"1","author":"Schickel","year":"2016","journal-title":"Sci Immunol"},{"key":"2021120808395434000_cei13101-bib-0036","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.766","article-title":"Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus","volume":"43","author":"Adrianto","year":"2011","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0037","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/hmg\/ddp193","article-title":"Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23","volume":"18","author":"Orozco","year":"2009","journal-title":"Hum Mol Genet"},{"key":"2021120808395434000_cei13101-bib-0038","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ng.2007.32","article-title":"Rheumatoid arthritis association at 6q23","volume":"39","author":"Thomson","year":"2007","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0039","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13059-016-1078-x","article-title":"Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23","volume":"17","author":"McGovern","year":"2016","journal-title":"Genome Biol"},{"key":"2021120808395434000_cei13101-bib-0040","doi-asserted-by":"crossref","first-page":"10069","DOI":"10.1038\/ncomms10069","article-title":"Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci","volume":"6","author":"Martin","year":"2015","journal-title":"Nat Commun"},{"key":"2021120808395434000_cei13101-bib-0041","author":"NIHR BioResource"},{"key":"2021120808395434000_cei13101-bib-0042","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrg3502","article-title":"Genetic insights into common pathways and complex relationships among immune-mediated diseases","volume":"14","author":"Parkes","year":"2013","journal-title":"Nat Rev Genet"},{"key":"2021120808395434000_cei13101-bib-0043","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrrheum.2016.131","article-title":"Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?","volume":"12","author":"van der Vlist","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2021120808395434000_cei13101-bib-0044","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00125-017-4210-x","article-title":"Painting a new picture of personalised medicine for diabetes","volume":"60","author":"McCarthy","year":"2017","journal-title":"Diabetologia"},{"key":"2021120808395434000_cei13101-bib-0046","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"2021120808395434000_cei13101-bib-0047","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0048","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(17)31474-5","article-title":"Interleukin 23 inhibitors for psoriasis: not just another number","volume":"390","author":"Bachelez","year":"2017","journal-title":"Lancet"},{"key":"2021120808395434000_cei13101-bib-0049","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"2021120808395434000_cei13101-bib-0050","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","article-title":"Ustekinumab induction and maintenance therapy in refractory Crohn's disease","volume":"367","author":"Sandborn","year":"2012","journal-title":"N Engl J Med"},{"key":"2021120808395434000_cei13101-bib-0051","doi-asserted-by":"crossref","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci Transl Med"},{"key":"2021120808395434000_cei13101-bib-0052","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"2021120808395434000_cei13101-bib-0053","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","article-title":"Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis","volume":"373","author":"Mease","year":"2015","journal-title":"N Engl J Med"},{"key":"2021120808395434000_cei13101-bib-0054","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"2021120808395434000_cei13101-bib-0055","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/gutjnl-2012-302525","article-title":"Seventeen in Crohn's disease: less prime than we thought?","volume":"61","author":"Raine","year":"2012","journal-title":"Gut"},{"key":"2021120808395434000_cei13101-bib-0056","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology","volume":"464","author":"Buonocore","year":"2010","journal-title":"Nature"},{"key":"2021120808395434000_cei13101-bib-0057","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"Papp","year":"2012","journal-title":"N Engl J Med"},{"key":"2021120808395434000_cei13101-bib-0058","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/ajg.2016.298","article-title":"A randomized, double-blind, placebo-controlled phase 2 study of brodalumab in patients with moderate-to-severe Crohn's disease","volume":"111","author":"Targan","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2021120808395434000_cei13101-bib-0059","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cyto.2011.08.026","article-title":"The role of tumor necrosis factor-alpha (TNF-alpha) in the pathogenesis of systemic lupus erythematosus","volume":"56","author":"Postal","year":"2011","journal-title":"Cytokine"},{"key":"2021120808395434000_cei13101-bib-0060","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature11307","article-title":"TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis","volume":"488","author":"Gregory","year":"2012","journal-title":"Nature"},{"key":"2021120808395434000_cei13101-bib-0061","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.2010.137174","article-title":"Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus","volume":"70","author":"Orozco","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021120808395434000_cei13101-bib-0062","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/14740338.7.4.411","article-title":"Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus","volume":"7","author":"Aringer","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"2021120808395434000_cei13101-bib-0063","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0090-1229(89)90157-8","article-title":"Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB\/NZW F1 mice","volume":"52","author":"Gordon","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"2021120808395434000_cei13101-bib-0064","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/1521-4141(200007)30:7<2038::AID-IMMU2038>3.0.CO;2-K","article-title":"Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Eur J Immunol"},{"key":"2021120808395434000_cei13101-bib-0065","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"key":"2021120808395434000_cei13101-bib-0066","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.2462","article-title":"High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis","volume":"44","author":"Eyre","year":"2012","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0067","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ng.2614","article-title":"Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis","volume":"45","author":"Hinks","year":"2013","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0068","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.174.3.561","article-title":"CTLA-4 is a second receptor for the B cell activation antigen B7","volume":"174","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"key":"2021120808395434000_cei13101-bib-0069","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMoa035075","article-title":"Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig","volume":"349","author":"Kremer","year":"2003","journal-title":"N Engl J Med"},{"key":"2021120808395434000_cei13101-bib-0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"2021120808395434000_cei13101-bib-0071","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"key":"2021120808395434000_cei13101-bib-0072","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/annrheumdis-2017-211555","article-title":"Novel therapies for immune-mediated inflammatory diseases: what can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?","volume":"77","author":"Baker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021120808395434000_cei13101-bib-0073","doi-asserted-by":"crossref","first-page":"e1003444","DOI":"10.1371\/journal.pgen.1003444","article-title":"Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases","volume":"9","author":"Ferreira","year":"2013","journal-title":"PLOS Genet"},{"key":"2021120808395434000_cei13101-bib-0074","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am J Transplant"},{"key":"2021120808395434000_cei13101-bib-0075","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.coi.2008.08.003","article-title":"Role of B cells in systemic lupus erythematosus and rheumatoid arthritis","volume":"20","author":"Mandik-Nayak","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"2021120808395434000_cei13101-bib-0076","doi-asserted-by":"crossref","first-page":"759868","DOI":"10.1155\/2010\/759868","article-title":"B-cell pathology in juvenile idiopathic arthritis","volume":"2010","author":"Wiegering","year":"2010","journal-title":"Arthritis"},{"key":"2021120808395434000_cei13101-bib-0077","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ng.3795","article-title":"Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-disease-associated loci in three major immune-cell types","volume":"49","author":"Chun","year":"2017","journal-title":"Nat Genet"},{"key":"2021120808395434000_cei13101-bib-0078","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/BOR.0000000000000411","article-title":"Genetic advances in systemic lupus erythematosus: an update","volume":"29","author":"Chen","year":"2017","journal-title":"Curr Opin Rheumatol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13101","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/193\/1\/3\/41645721\/cei13101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/193\/1\/3\/41645721\/cei13101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:28:10Z","timestamp":1641036490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/193\/1\/3\/6411900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,2,2]]},"published-print":{"date-parts":[[2018,7,10]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13101","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,2,2]]}}}